Princeton, NJ, October 11, 2024 – Sandoz, the global leader in generic and biosimilar medicines ... 100 mg of paclitaxel in a single-dose vial for intravenous use follows approval by the FDA on ...
Drug giant Eli Lilly has announced a $35 (£30) cap on the monthly costs patients face for insulin in the US, responding ... its non-branded insulin, Lispro, to $25 a vial, effective 1 May.